What happened
Genesystem updated the terms of a private placement (third-party allotment) to raise US$2.06M, about 8.5% of its market value.
For context, this raise equals about 8.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$2.06M |
| vs. market value | 8.5% |
| Filed | 2026-02-11, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260211001080 → open original filing |
Source: DART. Information only, not investment advice.